Cervel Neurotech

Cervel Neurotech

Signal active

Organization

Contact Information

Overview

Cervel Neurotech, Inc. (formerly NeoStim, Inc.) located in San Mateo, CA is a privately held medical device company that is pioneering an innovative, proprietary approach to non-invasive deep brain neuro-modulation. Cervel’s technology is a form of repetitive transcranial magnetic stimulation (rTMS) which uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas. The company was founded in 2008 by M. Bret Schneider, MD, and David J. Mishelevich, MD, PhD, and entrepreneur Michael J. Partsch, using technology licensed from Stanford Univesity.

Acquired by Rio Grande Neurosciences in 2015

About

Industries

Biotechnology, Health Care, Medical, Medical Device, Neuroscience

Founded

2008

Employees

11-50

Headquarters locations

Redwood City, California, United States, North America

Social

Profile Resume

Cervel Neurotech headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device, Neuroscience sector. The company focuses on Biotechnology and has secured $6.8B in funding across 160 round(s). With a team of 11-50 employees, Cervel Neurotech is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Cervel Neurotech, raised $14.1M. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

8

Investors

2

Lead Investors

0

Total Funding Amount

$42.5M

Details

2

Cervel Neurotech has raised a total of $42.5M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2008Early Stage Venture1.5M
2010Early Stage Venture7.5M

Investors

Cervel Neurotech is funded by 8 investors.

Investor NameLead InvestorFunding RoundPartners
Aberdare Ventures-FUNDING ROUND - Aberdare Ventures14.1M
Alex Wong-FUNDING ROUND - Alex Wong14.1M
Cervel Neurotech-FUNDING ROUND - Cervel Neurotech14.1M
D. E. Shaw & Co.-FUNDING ROUND - D. E. Shaw & Co.14.1M